Schedule 13G ownership disclosure

TRANSLATE BIO INC

Security class unavailable · CUSIP: 89374L104

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,922,008
Percent of class
6.5300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-010546
Form type
SC 13G/A
Filer
Atlas Venture Fund VIII, L.P.
CIK
CIK 1451626
Filed
Feb 04, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub